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Editorial
Dear Readers,
In this edition of Advances, we present articles on different aspects of common symptom management 
and rare clinical situations. I would like to draw your particular attention to the review by Zylicz and Merca-
dante.  Authors have challenged us with the statement that “despite a more than ten-fold increase in opioid 
consumption in the past decades, many cancer patients still suffer pain”. They hypothesize that unrecognized 
opioid-induced neurotoxicity is partially responsible for this situation. At the moment, the main evidence-based 
tool for dealing with this phenomenon is switching to another opioid; however, this might be a short-lived 
solution. Therefore, Zylicz and Mercadante discuss with each other the possibility of combining different 
opioids.  If you want to confront yourself with the question: “Is there enough evidence to advocate opioid 
combinations?” simply read this review. This topic is also touched upon by Bourne and Zylicz in their original 
publication. The main goal of their presented survey is to establish safe initial doses of buprenorfine patches 
for terminally-ill patients. However, the authors also present some very interesting and new conclusions on 
opioid switching and semi-switching based on their preliminary observations. The idea of semi-switching 
introduced by Mercadante et al. [1] means that, especially in a patient with a rapid tolerance development, 
instead of changing one opioid to another the dose of the first opioid should be decreased and a second 
opioid introduced.  This concept appears to be highly controversial for many healthcare professionals, as it 
might complicate treatment and increase the risk of mistakes. At the moment, the combination of opioids is 
regarded as the last resort treatment in rapid tolerance development.  There is no doubt that the concept of 
opioid switching and semi-switching should be carefully investigated. Nevertheless, palliative medicine spe-
cialists should bear in mind both rules of symptom management: “keep it simple” and the individualization 
of therapy.  Combining these attitudes is urgently required, especially in the more challenging situations. 
Prokop et al. present the case of a young patient with Ehlers-Danlos syndrome, who suffered from severe 
pain. Despite the well-known recommendation on the use of opioids in modified release preparations for 
non-cancer pain [2], the patient had to be treated for many years with normal release morphine due to great 
diurnal fluctuations of pain intensity. Good communication between physician and the patient allowed for 
such pain management. Pyszora and Krajnik also touch on the problem of the individualization of therapy. 
They describe the case of a patient for whom the addition of abdominal massage, myofascial release techni-
ques and exercises to the use of laxatives improved the management of constipation. In the next case report, 
Jeganath and Sivaguru propose the Mapleson-C circuit for improving lung expansion and airway clearance 
in a patient with neuromuscular disease after being weaned from mechanical ventilator support. If you do 
not know what a Mapleson-C circuit is (like myself!), you will have to read this article by our colleagues from 
India.  The last publication I would like to mention is a report by Turek at el. of a patient with a tumour of 
the palatine tonsil. Among other facts, the authors underline that the quality of medical care organization 
and social support might have an important impact on patients’ survival.  
I really hope you enjoy reading this whole issue of Advances and I also hope you accept this very special 
invitation to submit your own papers to our magazine. The European Association for Palliative Care in colla-
boration with Advances in Palliative Medicine wish to announce a special one-off prize for the author of an 
original paper published (or accepted for publication) in Advances in Palliative Medicine. The prize will include 
free registration, accommodation and a return economy flight ticket to enable the winner to attend the 12th 
Congress of the European Association for Palliative Care, to be held in Lisbon, Portugal on 19–21 May 2011. 
The competition is restricted to specialist colleagues working in Middle and Eastern European countries. 
The closing date for the receipt of manuscripts is 15 December 2010 and you can find more information on:
http://www.advpm.eu/en/author_prize.phtml
So, when you come back from your holiday, please get down to work! Good luck,
Małgorzata Krajnik
Editor-in-chief
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